Three KIYATEC abstracts accepted for poster presentations during 2016 AACR Conference in New Orleans
KIYATEC, a private company prioritizing accurate ex vivo prediction of patients’ response to drug treatment, received acceptance of three posters for presentations during the upcoming AACR conference.
GREENVILLE, SC, March 21, 2016– KIYATEC Inc. is pleased to announce that three abstracts have been accepted by the committee at the American Association for Cancer Research (www.aacr.org). KIYATEC scientific and business development staff will be in attendance at the conference. In addition to the poster presentations, also KIYATEC will be exhibiting at Booth 1050. Stop by to learn more about our 10+ years of 3D cell culture experience and the latest 3D co-culture model development projects focused on immuno-oncology applications.
- Abstract #611: A Complex 3D Model of Glioblastoma for Patient-Specific Drug Response Profiling | Sunday Apr 17, 2016 1:00 PM – 5:00 PM | Location: Section 28 / Poster 12
- Abstract #2531: Marker free isolation and expansion of cancer stem cells from small cell lung cancer | Monday, Apr 18, 2016, 1:00 PM – 5:00 PM | Location: Section 34 / Poster 20
- Abstract # 5119: Complex, 3D tissues for modeling the immune response in cancer and predicting the activity of immunotherapies | Wednesday Apr 20, 2016 8:00 AM – 12:00 PM | Location: Section 31 / Poster 5